Takayuki Yamada

6PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsMolecular targetsCharacterisation of biological macromoleculesRace/ethnicity and crime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 08, 2026
Subclinical and Borderline Rejection are Associated With Death-Censored Graft Loss After Kidney Transplantation: A Systematic Review and Meta-Analysis.

Takayuki Yamada, Shota Obata, Arjun Kalaria

|Oct 13, 2023
Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus.

Shunichiro Tsukamoto, Shohei Tanaka, Takayuki Yamada

|Jun 01, 2023
A Specific Target BP in Chronic Kidney Disease Remains Unclear.

Takayuki Yamada, Chethan M Puttarajappa, Csaba P Kovesdy

|Jan 12, 2023
Effects of sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients.

Ryutaro Morita, Shunichiro Tsukamoto, Shota Obata

|Jul 08, 2021
Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City.

Takayuki Yamada, Takahisa Mikami, Nitin Chopra

|May 28, 2020
Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City.

Takayuki Yamada, Takahisa Mikami, Nitin Chopra

Pageof 1

Frequent Collaborators

2 joint publications

Hiromichi Wakui

2 joint publications

Chethan Puttarajappa

1 joint publications

Csaba P Kovesdy

1 joint publications

Yoshitsugu Obi